PAVmed sub Lucid closes $21.95M convertible note placement; net $18.3M

PAVmed Inc.

Lucid Diagnostics (PAVmed sub) closed $21.95M in Senior Secured Convertible Notes to accredited investors.
Gross proceeds $21.95M; net proceeds after repaying prior 2023 Convertible Note ~$18.3M.
Transaction includes Registration Rights, Guaranty, and Security Pledge Agreements.
Notes are senior secured and convertible; terms incorporated by reference from Nov 29 filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.